UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Multiple Mutations and Bypass Mechanisms Can Contribute to Development of Acquired Resistance to MET Inhibitors

Cancer research (Chicago, Ill.), 2011-02, Vol.71 (3), p.1081-1091

2011

Volltextzugriff (PDF)

Nonclinical Antiangiogenesis and Antitumor Activities of Axitinib (AG-013736), an Oral, Potent, and Selective Inhibitor of Vascular Endothelial Growth Factor Receptor Tyrosine Kinases 1, 2, 3

Clinical cancer research, 2008-11, Vol.14 (22), p.7272-7283

2008

Volltextzugriff (PDF)

Missense mutations interfere with VEGFR-3 signalling in primary lymphoedema

Nature genetics, 2000-06, Vol.25 (2), p.153-159

2000

Volltextzugriff (PDF)

Analysis of lorlatinib analogs reveals a roadmap for targeting diverse compound resistance mutations in ALK-positive lung cancer

Nature cancer, 2022-06, Vol.3 (6), p.710-722

2022

Volltextzugriff (PDF)

Structure of Haemophilus influenzae Fe +3 -binding protein reveals convergent evolution within a superfamily

Nature structural & molecular biology, 1997-11, Vol.4 (11), p.919-924

1997

Volltextzugriff (PDF)

Enzymatic Characterization of c-Met Receptor Tyrosine Kinase Oncogenic Mutants and Kinetic Studies with Aminopyridine and Triazolopyrazine Inhibitors

Biochemistry (Easton), 2009-06, Vol.48 (23), p.5339-5349

2009

Volltextzugriff (PDF)

Mechanistic Effects of Autophosphorylation on Receptor Tyrosine Kinase Catalysis: Enzymatic Characterization of Tie2 and Phospho-Tie2

Biochemistry (Easton), 2001-08, Vol.40 (34), p.10243-10253

2001

Volltextzugriff (PDF)

Characterizing the Effects of the Juxtamembrane Domain on Vascular Endothelial Growth Factor Receptor-2 Enzymatic Activity, Autophosphorylation, and Inhibition by Axitinib

Biochemistry (Easton), 2009-07, Vol.48 (29), p.7019-7031

2009

Volltextzugriff (PDF)

Crystal structure of the kinase domain of human vascular endothelial growth factor receptor 2: a key enzyme in angiogenesis

Structure (London), 1999-03, Vol.7 (3), p.319-330

1999

Volltextzugriff (PDF)

Crystal structure of chicken liver dihydrofolate reductase complexed with NADP+ and biopterin

Biochemistry (Easton), 1992-08, Vol.31 (32), p.7264-7273

1992

Volltextzugriff (PDF)

Abstract 2327: Structural and kinetic characterization of crizotinib with wild-type and mutant anaplastic lymphoma kinase

Cancer research (Chicago, Ill.), 2011-04, Vol.71 (8_Supplement), p.2327-2327

2011

Volltextzugriff (PDF)

Crystal structures of a schistosomal drug and vaccine target: glutathione S-transferase from Schistosoma japonica and its complex with the leading antischistosomal drug praziquantel

Journal of molecular biology, 1995-02, Vol.246 (1), p.21-27

1995

Volltextzugriff (PDF)

Crystal structures of chicken liver dihydrofolate reductase: Binary thioNADP+ and ternary thioNADP+.cntdot.biopterin complexes

Biochemistry (Easton), 1993-07, Vol.32 (27), p.6855-6862

1993

Volltextzugriff (PDF)

Structure of Haemophilus influenzae Fe(+3)-binding protein reveals convergent evolution within a superfamily

Nature structural biology, 1997-11, Vol.4 (11), p.919-924

1997

Volltextzugriff (PDF)

Crystal Structures of a Schistosomal Drug and Vaccine Target: Glutathione S-Transferase fromSchistosoma japonicaand its Complex with the Leading Antischistomal Drug Praziquantel

Journal of molecular biology, 1995-02, Vol.246 (1), p.21-27

1995

Volltextzugriff (PDF)

Crystal Structures of a Schistosomal Drug and Vaccine Target: Glutathione S-Transferase from Schistosoma japonicaand its Complex with the Leading Antischistomal Drug Praziquantel

Journal of molecular biology, 1995, Vol.246 (1), p.21-27

1995

Volltextzugriff (PDF)

Crystal structures of chicken liver dihydrofolate reductase : binary ThioNADP+ and ternary ThioNADP+..biopterin complexes

Biochemistry (Easton), 1993-07, Vol.32 (27), p.6855-6862

1993

Volltextzugriff (PDF)

Purification and crystallization of a schistosomal glutathione S-Transferase

Proteins, structure, function, and bioinformatics, 1995-05, Vol.22 (1), p.55-57

1995

Volltextzugriff (PDF)

Basso Mouse Scale for locomotion detects differences in recovery after spinal cord injury in five common mouse strains

Journal of neurotrauma, 2006-05, Vol.23 (5), p.635-659

2006

Volltextzugriff (PDF)

Molecular conformations, interactions, and properties associated with drug efficiency and clinical performance among VEGFR TK inhibitors

Proceedings of the National Academy of Sciences - PNAS, 2012-11, Vol.109 (45), p.18281-18289

2012

Volltextzugriff (PDF)

Structure Based Drug Design of Crizotinib (PF-02341066), a Potent and Selective Dual Inhibitor of Mesenchymal–Epithelial Transition Factor (c-MET) Kinase and Anaplastic Lymphoma Kinase (ALK)

Journal of medicinal chemistry, 2011-09, Vol.54 (18), p.6342-6363

2011

Volltextzugriff (PDF)

PF-06463922 is a potent and selective next-generation ROS1/ALK inhibitor capable of blocking crizotinib-resistant ROS1 mutations

Proceedings of the National Academy of Sciences - PNAS, 2015-03, Vol.112 (11), p.3493-3498

2015

Volltextzugriff (PDF)

Discovery of PF-06873600, a CDK2/4/6 Inhibitor for the Treatment of Cancer

Journal of medicinal chemistry, 2021-07, Vol.64 (13), p.9056-9077

2021

Volltextzugriff (PDF)

Sleep Health Characteristics among Adults Who Attempted Weight Loss in the Past Year: NHANES 2017–2018

International journal of environmental research and public health, 2021-09, Vol.18 (19), p.10170

2021

Volltextzugriff (PDF)

Eccentric rehabilitation induces white matter plasticity and sensorimotor recovery in chronic spinal cord injury

Experimental neurology, 2021-12, Vol.346, p.113853-113853, Article 113853

2021

Volltextzugriff (PDF)

1 – 25 von 54

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(51)
Mit Volltextzugriff
(48)

Publikationsform

Sprache

Englisch
(54)
Japanisch
(13)

Erscheinungsjahr

n.n

Thema

Science & Technology
(33)
Life Sciences & Biomedicine
(29)
Humans
(25)
Animals
(16)
Models, Molecular
(14)
Biochemistry & Molecular Biology
(11)
Crystallography, X-Ray
(11)
Mice
(11)
Mutation
(11)
Protein Kinase Inhibitors - Pharmacology
(11)
Female
(9)
Chemistry, Medicinal
(8)
Pharmacology & Pharmacy
(8)
Protein Conformation
(8)
Binding Sites
(7)
Phosphorylation
(7)
Amino Acid Sequence
(6)
Cell Line, Tumor
(6)
Drug Resistance, Neoplasm - Genetics
(6)
Kinases
(6)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Multiple Mutations and Bypass Mechanisms Can Contribute to Development of Acquired Resistance to MET Inhibitors

Nonclinical Antiangiogenesis and Antitumor Activities of Axitinib (AG-013736), an Oral, Potent, and Selective Inhibitor of Vascular Endothelial Growth Factor Receptor Tyrosine Kinases 1, 2, 3

Missense mutations interfere with VEGFR-3 signalling in primary lymphoedema

Analysis of lorlatinib analogs reveals a roadmap for targeting diverse compound resistance mutations in ALK-positive lung cancer

Structure of Haemophilus influenzae Fe +3 -binding protein reveals convergent evolution within a superfamily

Enzymatic Characterization of c-Met Receptor Tyrosine Kinase Oncogenic Mutants and Kinetic Studies with Aminopyridine and Triazolopyrazine Inhibitors

Mechanistic Effects of Autophosphorylation on Receptor Tyrosine Kinase Catalysis: Enzymatic Characterization of Tie2 and Phospho-Tie2

Characterizing the Effects of the Juxtamembrane Domain on Vascular Endothelial Growth Factor Receptor-2 Enzymatic Activity, Autophosphorylation, and Inhibition by Axitinib

Crystal structure of the kinase domain of human vascular endothelial growth factor receptor 2: a key enzyme in angiogenesis

Crystal structure of chicken liver dihydrofolate reductase complexed with NADP+ and biopterin

Abstract 2327: Structural and kinetic characterization of crizotinib with wild-type and mutant anaplastic lymphoma kinase

Crystal structures of a schistosomal drug and vaccine target: glutathione S-transferase from Schistosoma japonica and its complex with the leading antischistosomal drug praziquantel

Crystal structures of chicken liver dihydrofolate reductase: Binary thioNADP+ and ternary thioNADP+.cntdot.biopterin complexes

Structure of Haemophilus influenzae Fe(+3)-binding protein reveals convergent evolution within a superfamily

Crystal Structures of a Schistosomal Drug and Vaccine Target: Glutathione S-Transferase fromSchistosoma japonicaand its Complex with the Leading Antischistomal Drug Praziquantel

Crystal Structures of a Schistosomal Drug and Vaccine Target: Glutathione S-Transferase from Schistosoma japonicaand its Complex with the Leading Antischistomal Drug Praziquantel

Crystal structures of chicken liver dihydrofolate reductase : binary ThioNADP+ and ternary ThioNADP+..biopterin complexes

Purification and crystallization of a schistosomal glutathione S-Transferase

Basso Mouse Scale for locomotion detects differences in recovery after spinal cord injury in five common mouse strains

Molecular conformations, interactions, and properties associated with drug efficiency and clinical performance among VEGFR TK inhibitors

Structure Based Drug Design of Crizotinib (PF-02341066), a Potent and Selective Dual Inhibitor of Mesenchymal–Epithelial Transition Factor (c-MET) Kinase and Anaplastic Lymphoma Kinase (ALK)

PF-06463922 is a potent and selective next-generation ROS1/ALK inhibitor capable of blocking crizotinib-resistant ROS1 mutations

Discovery of PF-06873600, a CDK2/4/6 Inhibitor for the Treatment of Cancer

Sleep Health Characteristics among Adults Who Attempted Weight Loss in the Past Year: NHANES 2017–2018

Eccentric rehabilitation induces white matter plasticity and sensorimotor recovery in chronic spinal cord injury

Suchergebnisse filtern